Abbott (ABT) Tops Q1 EPS by 10c, Offers FY Guidance
Get Alerts ABT Hot Sheet
Price: $105.27 --0%
EPS Growth %: -4.9%
Financial Fact:
Dilutive Common Stock Options and Awards (in shares): 0
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: -4.9%
Financial Fact:
Dilutive Common Stock Options and Awards (in shares): 0
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q1 EPS of $1.45, $0.10 better than the analyst estimate of $1.35. Revenue for the quarter came in at $10.7 billion versus the consensus estimate of $9.94 billion.
GUIDANCE:
Abbott sees 2021 EPS of at least $5.00, versus the consensus of $4.37.
- Abbott projects full-year 2021 diluted earnings per share from continuing operations under GAAP of at least $3.74. Abbott forecasts specified items for the full-year 2021 of $1.26 primarily related to intangible amortization, expenses associated with acquisitions, restructuring and cost reduction initiatives and other net expenses. Excluding specified items, projected adjusted diluted earnings per share from continuing operations would be at least $5.00 for full-year 2021.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Procter & Gamble (PG) Tops Q3 EPS by 11c, Revenues Miss
- Hilltop Holdings (HTH) Tops Q1 EPS by 17c
- Provident Financial Services (PFS) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!